102 related articles for article (PubMed ID: 14608868)
41. Beta-catenin is temporally regulated during normal liver development.
Micsenyi A; Tan X; Sneddon T; Luo JH; Michalopoulos GK; Monga SP
Gastroenterology; 2004 Apr; 126(4):1134-46. PubMed ID: 15057752
[TBL] [Abstract][Full Text] [Related]
42. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
43. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
[TBL] [Abstract][Full Text] [Related]
44. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration.
Monga SP; Pediaditakis P; Mule K; Stolz DB; Michalopoulos GK
Hepatology; 2001 May; 33(5):1098-109. PubMed ID: 11343237
[TBL] [Abstract][Full Text] [Related]
45. Exchange of catenins in cadherin-catenin complex.
Klingelhöfer J; Troyanovsky RB; Laur OY; Troyanovsky S
Oncogene; 2003 Feb; 22(8):1181-8. PubMed ID: 12606944
[TBL] [Abstract][Full Text] [Related]
46. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
47. The significance of E-cadherin and alpha-, beta-, and gamma-catenin expression in surgically treated non-small cell lung cancers of 3 cm or less in size.
Lee YC; Wu CT; Chen CS; Hsu HH; Chang YL
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):502-7. PubMed ID: 11882822
[TBL] [Abstract][Full Text] [Related]
48. beta-Catenin associates with the actin-bundling protein fascin in a noncadherin complex.
Tao YS; Edwards RA; Tubb B; Wang S; Bryan J; McCrea PD
J Cell Biol; 1996 Sep; 134(5):1271-81. PubMed ID: 8794867
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
50. E, N-cadherins and beta-catenin expression in medulloblastoma and atypical teratoid/rhabdoid tumor.
Utsuki S; Oka H; Sato Y; Tsutiya B; Kondo K; Tanizaki Y; Tanaka S; Fujii K
Neurol Med Chir (Tokyo); 2004 Aug; 44(8):402-6; discussion 407. PubMed ID: 15508347
[TBL] [Abstract][Full Text] [Related]
51. The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies.
Trent JM; Wiltshire R; Su LK; Nicolaides NC; Vogelstein B; Kinzler KW
Cytogenet Cell Genet; 1995; 71(4):343-4. PubMed ID: 8521721
[TBL] [Abstract][Full Text] [Related]
52. Subcellular distribution of Wnt pathway proteins in normal and neoplastic colon.
Anderson CB; Neufeld KL; White RL
Proc Natl Acad Sci U S A; 2002 Jun; 99(13):8683-8. PubMed ID: 12072559
[TBL] [Abstract][Full Text] [Related]
53. All-trans-retinoic acid-dependent inhibition of E-cadherin-based cell adhesion with concomitant dephosphorylation of beta-catenin in metastatic human renal carcinoma cells.
Ryuto M; Jimi S; Ono M; Naito S; Nakayama Y; Yamada Y; Komiyama S; Kuwano M
Jpn J Cancer Res; 1997 Oct; 88(10):982-91. PubMed ID: 9414661
[TBL] [Abstract][Full Text] [Related]
54. [Expression patterns of E-cadherin and beta-catenin according to clinicopathological characteristics of hepatocellular carcinoma].
Bae SH; Jung ES; Park YM; Jang JW; Choi JY; Cho SH; Yoon SK; Ahn BM; Cha SB; Chung KW; Sun HS; Park DH; Kim BK; Kim DG
Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):297-303. PubMed ID: 12499787
[TBL] [Abstract][Full Text] [Related]
55. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
56. beta-Catenin: a pivot between cell adhesion and Wnt signalling.
Bienz M
Curr Biol; 2005 Jan; 15(2):R64-7. PubMed ID: 15668160
[TBL] [Abstract][Full Text] [Related]
57. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon.
Hardy RG; Tselepis C; Hoyland J; Wallis Y; Pretlow TP; Talbot I; Sanders DS; Matthews G; Morton D; Jankowski JA
Gut; 2002 Apr; 50(4):513-9. PubMed ID: 11889072
[TBL] [Abstract][Full Text] [Related]
58. E-cadherin and APC compete for the interaction with beta-catenin and the cytoskeleton.
Hülsken J; Birchmeier W; Behrens J
J Cell Biol; 1994 Dec; 127(6 Pt 2):2061-9. PubMed ID: 7806582
[TBL] [Abstract][Full Text] [Related]
59. The cadherin-catenin complex as a focal point of cell adhesion and signalling: new insights from three-dimensional structures.
Gooding JM; Yap KL; Ikura M
Bioessays; 2004 May; 26(5):497-511. PubMed ID: 15112230
[TBL] [Abstract][Full Text] [Related]
60. The interaction between beta-catenin, GSK3beta and APC after motogen induced cell-cell dissociation, and their involvement in signal transduction pathways in prostate cancer.
Davies G; Jiang WG; Mason MD
Int J Oncol; 2001 Apr; 18(4):843-7. PubMed ID: 11251183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
